ORIC Pharmaceuticals Inc.
ORIC | NASDAQ
$13.30
+$0.63 (+4.97%)
Sep 22, 2026, 2:29 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 584K | 320K | 320K | 304K | 304K | 304K | 565K | 524K | 524K | 524K | 263K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -584K | -320K | -320K | -304K | -304K | -304K | -565K | -524K | -524K | -524K | -263K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -156.14M | -149.91M | -143M | -148.02M | -149.67M | -146.62M | -142.9M | -134.75M | -125.12M | -114.09M | -110.78M | -101.47M | -98.48M | -94.19M | -91.77M | -92.45M | -85.22M | -85.58M | -78.87M | -84.35M | -91.49M | -81.56M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 4.05M | 8.03M | 11.13M | 14.34M | 12.33M | 10.08M | 8.26M | 5.92M | 4.28M | 2.65M | 1.41M | 572K | 196K | 141K | 137K | 117K | 109K |
Pretax Income | -140.35M | -135.21M | -129.47M | -135.27M | -137.25M | -132.86M | -127.85M | -119.87M | -110.78M | -101.76M | -100.7M | -93.21M | -92.57M | -89.91M | -89.12M | -91.05M | -84.64M | -85.37M | -78.72M | -84.2M | -91.33M | -81.34M |
Net Income | -140.35M | -135.21M | -129.47M | -135.27M | -137.25M | -132.86M | -127.85M | -119.87M | -110.78M | -101.76M | -100.7M | -93.21M | -92.57M | -89.91M | -89.12M | -91.05M | -84.64M | -85.37M | -78.72M | -84.2M | -91.33M | -81.34M |
Selling & General & Admin | 33.78M | 33.29M | 33.19M | 31.79M | 31.01M | 29.57M | 28.26M | 27.65M | 26.82M | 25.95M | 25.35M | 24.49M | 24.16M | 24.82M | 25.09M | 25.32M | 24.91M | 23.59M | 22.01M | 20.25M | 18.49M | 16.35M |
Research & Development | 122.36M | 116.62M | 109.82M | 115.93M | 118.36M | 116.75M | 114.07M | 106.58M | 97.77M | 87.62M | 85.17M | 76.99M | 69.32M | 64.37M | 61.68M | 62.13M | 60.31M | 61.99M | 56.86M | 52.23M | 48.16M | 40.36M |
Other Expenses | -584K | -320K | -320K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5M | 5M | 5M | 5M | n/a | n/a | n/a | 11.87M | 24.84M | 24.84M |
Operating Expenses | 155.55M | 149.59M | 142.68M | 147.72M | 149.37M | 146.32M | 142.33M | 134.23M | 124.59M | 113.57M | 110.52M | 101.47M | 98.48M | 94.19M | 91.77M | 92.45M | 85.22M | 85.58M | 78.87M | 84.35M | 91.49M | 81.56M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.99M | 1.99M | 1.99M | 1.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -261K | -261K | -261K | -261K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 156.14M | 149.91M | 143M | 148.02M | 149.67M | 146.62M | 142.9M | 134.75M | 125.12M | 114.09M | 110.78M | 101.47M | 98.48M | 94.19M | 91.77M | 92.45M | 85.22M | 85.58M | 78.87M | 84.35M | 91.49M | 81.56M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 108.01M | 105.47M | 87.79M | 98.95M | 78.13M | 71.04M | 70.65M | 70.54M | 70.35M | 67.35M | 57.46M | 57.4M | 45.65M | 45.09M | 40.13M | 39.58M | 39.48M | 39.43M | 39.19M | 39.01M | 36.7M | 36.68M |
Shares Outstanding (Diluted) | 108.01M | 105.47M | 87.79M | 98.95M | 78.13M | 71.04M | 70.65M | 70.54M | 70.35M | 67.35M | 57.46M | 57.4M | 45.65M | 45.09M | 40.13M | 39.58M | 39.48M | 39.43M | 39.39M | 39.01M | 36.7M | 36.68M |
EPS (Basic) | -1.35 | -1.44 | -1.52 | -1.73 | -1.89 | -1.87 | -1.82 | -1.80 | -1.75 | -1.80 | -1.96 | -1.99 | -2.18 | -2.19 | -2.25 | -2.31 | -2.15 | -2.21 | -2.07 | -2.33 | -2.70 | -2.64 |
EPS (Diluted) | -1.35 | -1.44 | -1.52 | -1.73 | -1.89 | -1.87 | -1.82 | -1.80 | -1.75 | -1.80 | -1.96 | -1.99 | -2.18 | -2.19 | -2.25 | -2.31 | -2.15 | -2.21 | -2.07 | -2.33 | -2.70 | -2.64 |
EBITDA | -143.28M | -134.03M | -128.25M | -134.07M | -136.06M | -131.71M | -126.74M | -118.8M | -109.73M | -100.72M | -99.67M | -92.2M | -87.45M | -84.81M | -84.02M | -85.96M | -83.7M | -84.45M | -77.86M | -71.5M | -65.68M | -55.77M |
EBIT | -144.16M | -135.21M | -129.47M | -135.27M | -137.25M | -132.86M | -127.85M | -119.87M | -110.78M | -101.76M | -100.7M | -93.21M | -88.43M | -85.77M | -84.99M | -86.91M | -84.64M | -85.37M | -78.76M | -72.4M | -66.6M | -56.72M |
Depreciation & Amortization | 1.14M | 1.19M | 1.22M | 1.2M | 1.19M | 1.15M | 1.11M | 1.07M | 1.05M | 1.04M | 1.03M | 1.02M | 980K | 968K | 966K | 948K | 944K | 919K | 897K | 902K | 925K | 949K |
Add to Watchlist
Select watchlists to add or remove ORIC